<DrugInformationSummary id="CDR0000787910"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Avelumab is a type of drug called an immune checkpoint inhibitor. It works by binding to the protein PD-L1 on the surface of some cancer cells, which keeps cancer cells from suppressing the immune system. This allows the immune system to attack the cancer cells.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/avelumab">Avelumab</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000745752">Avelumab</TerminologyLink><GlossaryLink ref="CDR0000787903">avelumab</GlossaryLink><USBrandNames><USBrandName>Bavencio</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>a-VEL-yoo-mab</TermPronunciation><MediaLink ref="CDR0000788393" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000788392" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5cd725a1-2fa4-408a-a651-57a7b84b2118&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Avelumab</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5cd725a1-2fa4-408a-a651-57a7b84b2118&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Avelumab
         is approved to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   <ListItem><Strong><GlossaryTermRef href="CDR0000658511" dictionary="Cancer.gov" audience="Patient">Merkel cell carcinoma</GlossaryTermRef></Strong> (a type of <GlossaryTermRef href="CDR0000445084" dictionary="Cancer.gov" audience="Patient">skin cancer</GlossaryTermRef>) that has spread.  It is used in adults and in children aged 12 years and older.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000661352" dictionary="Cancer.gov" audience="Patient">Renal cell carcinoma</GlossaryTermRef></Strong> (a type of <GlossaryTermRef href="CDR0000444995" dictionary="Cancer.gov" audience="Patient">kidney cancer</GlossaryTermRef>) that has spread or cannot be removed by surgery. It is used with <GlossaryTermRef href="CDR0000538635" dictionary="Cancer.gov" audience="Patient">axitinib</GlossaryTermRef> as the first treatment.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000783188" dictionary="Cancer.gov" audience="Patient">Urothelial cancer</GlossaryTermRef></Strong> (a type of cancer in the <GlossaryTermRef href="CDR0000046501" dictionary="Cancer.gov" audience="Patient">bladder</GlossaryTermRef> or <GlossaryTermRef href="CDR0000046095" dictionary="Cancer.gov" audience="Patient">urinary tract</GlossaryTermRef>) that has spread or cannot be removed by surgery. It is used:<ItemizedList Style="bullet" id="_6"><ListItem>As  <GlossaryTermRef href="CDR0000045768" dictionary="Cancer.gov" audience="Patient">maintenance therapy</GlossaryTermRef> in patients whose cancer did not get worse after first-line <GlossaryTermRef href="CDR0000045841" dictionary="Cancer.gov" audience="Patient">platinum</GlossaryTermRef> chemotherapy.</ListItem><ListItem>In patients whose cancer got worse during or after treatment with platinum chemotherapy.</ListItem></ItemizedList> </ListItem>
   </ItemizedList>
  <Para id="_4">Avelumab
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Avelumab</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/745752">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.71">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a617006.html">Avelumab</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.72"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.73">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2023/bladder-cancer-padcev-keytruda-doubles-survival">Groundbreaking Trial Results Expand Treatment Options for Some People with Bladder Cancer Effects</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2022/immunotherapy-myocarditis-cause">Study Identifies a Potential Cause of Immunotherapy’s Heart-Related Side Effects</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/news-events/cancer-currents-blog/2022/immunotherapy-cancer-biomarker-hla-gene">Cancer Immunotherapies Don’t Work for Everyone: HLA Gene May Explain Why</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies">Monoclonal Antibodies</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors">Immune Checkpoint Inhibitors</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C116870">Find Clinical Trials for Avelumab</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2017-03-31</DateFirstPublished><DateLastModified>2024-04-01</DateLastModified></DrugInformationSummary>
